Death by a thousand cuts: granzyme pathways of programmed cell death.
By Dipanjan Chowdhury, J. Lieberman. Annual Review of Immunology, 2008
708 citations recorded by the source corpus.
Subfields: Immunology, Physiology
View Paper: https://www.semanticscholar.org/paper/3c1c74fa546b306ccd6051025394bb7221f386eb
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- L. Martínez-Lostao
- Peng Yang
- J. Pardo
- Chaoqiang Qiao
- Feng Xie
- Zhiping Rao
- Wei-Jing Liu
- Zhuang Chen
Citations in the corpus
- Pyroptosis in inflammatory diseases and cancer (2022, background): “However, there are many reports have shown that GZMA fails to kill target cells in vitro unless very high concentrations are used [44-46].”
- How Do Cytotoxic Lymphocytes Kill Cancer Cells? (2015, background): “Several GZMs, including human and mouse GZMA, GZMB, GZMK, and GZMM, as well as human GZMH or mouse GZMC, have been shown to induce cell death in vitro by using purified molecules (6, 8, 18).”
- Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1 (2018, neutral): “CD8CTL, the major effector of antitumor immunity, eliminates cancer cells by secreting granzyme B (GB), an apoptosis trigger (Chowdhury and Lieberman, 2008).”
- Role of pyroptosis in inflammation and cancer (2022, background): “Granzyme B is also the most abundant granzyme in cytotoxic granules and is transported to cancer cells, where it cleaves caspase-3 and perforin to induce apoptosis [128, 129].”